Author:
André Thierry,Dumont Sarah N.
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference5 articles.
1. Rapport INCa « La situation du Cancer en France en 2011 » - http://www.ecancer.fr/component/docman/doc_download/7708-la-situation-du-cancer-en-france-en-2011
2. A phase I dose-escalation study of régorafénib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors;Mross;Clinical cancer research : an official journal of the American Association for Cancer Research,2012
3. Régorafénib (BAY 73-4506) in advanced colorectal cancer: a phase I study;Strumberg;British journal of cancer,2012
4. For the CORRECT Study Group. Régorafénib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Grothey;Lancet,2013
5. Correspondance. Is there room for optimizing régorafénib in metastatic colorectal cancer and advanced gastrointestinal stromal tumors?;André;Lancet,2013
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献